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HIV-1C of southern Africa shows higher rates of genomic
variation than does HIV-1B. Prevalence rates are far higher
in this region as compared to elsewhere in sub-Saharan
Africa or in the world. Enhanced rates of transcriptional
activation, presumably related to duplication in the LTR
NF-kB enhancer region of the genome, have been well
documented. This may in turn be associated with better
replication in vaginal and GALT tissues, different patterns
of mother/infant transmission, and elevated transmission
rates. HIV-1C has also been shown to have higher rates of
nevirapine resistance in mothers given labor nevirapine,
higher rates of K65R resistance to tenofovir after in vitro
selection, different patterns of accumulation of thymide
analogue mutations to the nucleoside analogue drugs,
and different patterns of mutations to the protease inhib-
itor drugs. HIV-1C also shows different patterns of immu-
noselection for immunodominant epitopes to both CTL
and antibody responses. With the gag gene epitopes, for
example, the p17 region is immunodominant in HIV-1B
while the p24 region is immunodominant for HIV-1C.
How these responses may be related to differences in
major histocompatibility alleles in the people of southern
Africa is unclear.
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